Patent Daily RSS
Twitter Guna
- Access the Bayer’s appeal - bit.ly/Lj9RMP 6 days ago
- Bayer seeks to stay the operation of the CL order - bit.ly/JBAlIS 6 days ago
- USPTO Offers Patent Applicants Option to Supplement Disclosure of Prior Art After Paying Issue Fee - bit.ly/Ju5BYd 1 week ago
- Piramal Healthcare to buy US firm to boost R&D - bit.ly/MiVA1V 1 week ago
- Financial challenges, novel drug devpt pressures to hamper India’s R&D growth: Expert - bit.ly/JHsWnw 1 week ago
- Biotech body criticises Bayer on cancer drug - bit.ly/J5DEpF 1 week ago
- India drugs inquiry could prompt new U.S. scrutiny - reut.rs/JDVT5y 1 week ago
- Cipla breached patent rights by slashing cancer drug price: Bayer - bit.ly/JyCBys 2 weeks ago
- No pharma application pending for compulsory licence: Govt - bit.ly/K3OUQy 2 weeks ago
- India’s patent protection regime to be key issue in talks with US - bit.ly/Jfhluh 2 weeks ago
Monthly Archives: November 2011
Common Citation Document Application (CCD)
[http://www.trilateral.net/ccd] Common Citation Document (CCD) Application is web based patent information tool developed by trilateral offices (USPTO, EPO & JPO) to provide single point access to citation data for their examined patent applications. It consolidates the prior cited by all three … Continue reading
Lipitor generic predictions
As Nov 30 approaches and Pfizer prepares to lose exclusivity on Lipitor, analysts are offering a variety of theories [Settelement bwt Ranbaxy and Pfizer] =============================================================== ….Two of Ranbaxy’s India plants have been banned by the USFDA. While Ranbaxy is confident … Continue reading
Presumption of patent validity in granting interim injunction
[Order] [SpicyIP] A granted patent can not be presumed to be valid. The presumption of patent validity is very less when defendant shows substantial doubts on violation of procedures in patent grant and credible challenge on patentibility and also when patent is granted recently. … Continue reading
Posted in Daily interesting IP news, Patent case, Uncategorized
Tagged 240893, Injunction, Tenxc
Leave a comment
Bayer Vs Controller of patents
[SpicyIP] [Order] Yesterday, a interesting news is posted in SpicyIP blog. Bayer challenges ambiguity in statutory language of “prima facie case” of section 87(1). Controller has published Natco’s compulsory license as per section 87(1) as prima facie case made out (published on Aug 12th … Continue reading
Posted in Daily interesting IP news, Patent case
Tagged Bayer, Compulsory license, natco, sorafenib
1 Comment
Claim format Indian patent applications
In a recently uploaded decision in ipindia which is related to Humira dosing regimen patent, patent applicant successfully traverse 3(e) and 3(i) grounds of opposition. Patent application no 6618/DELNP/2006 and titled: “MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNF -RELATED DISORDERS“, Patent applicant is Abbott and … Continue reading
Ranbaxy-MMV-Antimalarial
Today Economic times reported that Ranbaxy received conditional approval for combination of its NCE molecule (Arterolane) and piperaquine phosphate. Drug Controller General of India ( DCGI) Surinder Singh said the marketing licence was subject to the condition that the Chinese plant … Continue reading
Google reader problem
Recently Google announced that some upcoming changes to Google reader. I have been using Google reader for my blog PATENTDAILY to instantly share important news and make prefect topic wise news display/aggregation. Now Google removed my most used features like … Continue reading
